ATE500256T1 - Neue kondensierte pyrrolocarbazole - Google Patents

Neue kondensierte pyrrolocarbazole

Info

Publication number: ATE500256T1
Authority: AT; Austria
Prior art keywords: new condensed; condensed pyrrolocarbazoles; pyrrolocarbazoles; new; condensed
Prior art date: 2003-12-23

Application number

AT04815262T

Other languages

English (en)

Inventor

Nadine Becknell

James Diebold

Diane Gingrich

Robert Hudkins

Dandu Reddy

Ming Tao

Theodore UNDERINER

Allison Zulli

Original Assignee

Cephalon Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-23

Filing date

2004-12-23

Publication date

2011-03-15

2004-12-23 Application filed by Cephalon Inc filed Critical Cephalon Inc

2011-03-15 Application granted granted Critical

2011-03-15 Publication of ATE500256T1 publication Critical patent/ATE500256T1/de

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Vascular Medicine (AREA)
Dermatology (AREA)
Virology (AREA)
Rheumatology (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Oncology (AREA)
Physical Education & Sports Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
Communicable Diseases (AREA)
Ophthalmology & Optometry (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Molecular Biology (AREA)
Immunology (AREA)
AIDS & HIV (AREA)
Hematology (AREA)
Endocrinology (AREA)

AT04815262T 2003-12-23 2004-12-23 Neue kondensierte pyrrolocarbazole ATE500256T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US53218203P	2003-12-23	2003-12-23
US11/017,947 US7169802B2 (en)	2003-12-23	2004-12-22	Fused pyrrolocarbazoles
PCT/US2004/043160 WO2005063763A1 (en)	2003-12-23	2004-12-23	Novel fused pyrrolocarbazoles

Publications (1)

Publication Number	Publication Date
ATE500256T1 true ATE500256T1 (de)	2011-03-15

Family

ID=34703676

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04815262T ATE500256T1 (de)	2003-12-23	2004-12-23	Neue kondensierte pyrrolocarbazole

Country Status (29)

Country	Link
US (4)	US7169802B2 (de)
EP (1)	EP1704148B1 (de)
JP (1)	JP5006046B2 (de)
KR (2)	KR101179372B1 (de)
CN (1)	CN1918162B (de)
AR (1)	AR047168A1 (de)
AT (1)	ATE500256T1 (de)
AU (1)	AU2004309394B2 (de)
BR (1)	BRPI0418113B8 (de)
CA (1)	CA2549627C (de)
CR (1)	CR8519A (de)
CY (1)	CY1111524T1 (de)
DE (1)	DE602004031672D1 (de)
DK (1)	DK1704148T3 (de)
EA (1)	EA012295B1 (de)
HR (1)	HRP20110373T1 (de)
IL (1)	IL176384A (de)
IS (1)	IS8519A (de)
MA (1)	MA28298A1 (de)
MY (2)	MY158159A (de)
NO (2)	NO336893B1 (de)
NZ (1)	NZ548099A (de)
PL (1)	PL1704148T3 (de)
PT (1)	PT1704148E (de)
RS (1)	RS51886B (de)
SG (1)	SG149045A1 (de)
SI (1)	SI1704148T1 (de)
TW (1)	TWI355385B (de)
WO (1)	WO2005063763A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060276497A1 (en) *	2000-05-09	2006-12-07	Cephalon, Inc.	Novel multicyclic compounds and the use thereof
US7241779B2 (en) *	2003-12-23	2007-07-10	Cephalon, Inc.	Fused pyrrolocarbazoles
SE0401790D0 (sv) *	2004-07-07	2004-07-07	Forskarpatent I Syd Ab	Tamoxifen response in pre- and postmenopausal breast cancer patients
WO2008028301A1 (en) *	2006-09-08	2008-03-13	Merck Frosst Canada Ltd.	Prodrugs of inhibitors of cathepsin s
US20080125377A1 (en) *	2006-11-28	2008-05-29	Bartels Stephen P	Delivery system for antiangiogenic and antiinflammatory pharmaceuticals and method of use
WO2008151323A1 (en) *	2007-06-08	2008-12-11	University Of Massachusetts	Mixed lineage kinases and metabolic disorders
AR069501A1 (es)	2007-11-30	2010-01-27	Genentech Inc	Anticuerpos anti- vegf (factor de crecimiento endotelial vascular)
UA107652C2 (en) *	2008-10-06	2015-02-10	Incuron Llc	Carbazole compounds and therapeutic uses of the compounds
SG195557A1 (en)	2008-10-22	2013-12-30	Genentech Inc	Modulation of axon degeneration
CN102216306B (zh) *	2008-11-19	2014-12-24	赛福伦公司	吲唑并[5,4-a]吡咯并[3,4-c]咔唑化合物的新形式
EP2192121A1 (de)	2008-11-27	2010-06-02	Cephalon France	Regioselektive Reduktion von fusionierten Pyrrolocarbazol-5,7-Dionen
CA2748491C (en) *	2008-12-30	2019-08-06	Arqule, Inc.	Substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
CA2748276A1 (en) *	2008-12-30	2010-07-08	Arqule, Inc.	Substituted pyrazolo [3, 4-b] pyridine compounds
MX2012004638A (es) *	2009-10-22	2012-07-04	Genentech Inc	Modulacion de degeneracion de axones.
US20110189174A1 (en)	2010-02-01	2011-08-04	Afshin Shafiee	Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization
UA108498C2 (en) *	2010-05-18	2015-05-12	Cephalon Inc	Condensed pirolokarbazol derivative purifying method
CN103664797A (zh) *	2012-09-25	2014-03-26	杨子娇	一类治疗房角狭窄的化合物及其用途
CN104370880A (zh) *	2013-01-24	2015-02-25	韩冰	一类蛋白酶抑制剂及其制备方法和用途
CN104981697B (zh)	2013-02-11	2017-08-04	英丘伦有限责任公司	促染色质转录复合物(fact)在癌症中的用途
US9884853B2 (en) *	2013-09-26	2018-02-06	Chdi Foundation, Inc.	Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
WO2015157172A1 (en)	2014-04-06	2015-10-15	Incuron, Llc	Combination therapies with curaxins

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ245203A (en)	1991-11-29	1997-07-27	Banyu Pharma Co Ltd	5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
US5594009A (en) *	1994-10-14	1997-01-14	Cephalon, Inc.	Fused pyrrolocarbazoles
US5475110A (en) *	1994-10-14	1995-12-12	Cephalon, Inc.	Fused Pyrrolocarbazoles
US5591855A (en) *	1994-10-14	1997-01-07	Cephalon, Inc.	Fused pyrrolocarbazoles
US5705511A (en)	1994-10-14	1998-01-06	Cephalon, Inc.	Fused pyrrolocarbazoles
US5616724A (en) *	1996-02-21	1997-04-01	Cephalon, Inc.	Fused pyrrolo[2,3-c]carbazole-6-ones
NZ333536A (en)	1996-08-22	1999-10-28	Bristol Myers Squibb Co	Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles, and use as antitumour agents
US6841567B1 (en) *	1999-02-12	2005-01-11	Cephalon, Inc.	Cyclic substituted fused pyrrolocarbazoles and isoindolones
US6399780B1 (en)	1999-08-20	2002-06-04	Cephalon, Inc.	Isomeric fused pyrrolocarbazoles and isoindolones
US6630500B2 (en) *	2000-08-25	2003-10-07	Cephalon, Inc.	Selected fused pyrrolocarbazoles
DK1325011T3 (da) *	2000-09-29	2004-08-16	Lilly Co Eli	Fremgangsmåder og forbindelser til behandling af proliferative sygdomme
US6653290B2 (en)	2000-10-06	2003-11-25	Bristol-Myers Squibb Company	Tumor proliferation inhibitors
US6610727B2 (en)	2000-10-06	2003-08-26	Bristol-Myers Squibb Company	Anhydro sugar derivatives of indolocarbazoles
US7018999B2 (en)	2001-05-16	2006-03-28	Cephalon, Inc.	Methods for the treatment and prevention of pain
US7241779B2 (en) *	2003-12-23	2007-07-10	Cephalon, Inc.	Fused pyrrolocarbazoles

2004
- 2004-12-22 US US11/017,947 patent/US7169802B2/en not_active Expired - Lifetime
- 2004-12-23 TW TW093140222A patent/TWI355385B/zh not_active IP Right Cessation
- 2004-12-23 MY MYPI20093362A patent/MY158159A/en unknown
- 2004-12-23 KR KR1020067014792A patent/KR101179372B1/ko not_active Expired - Fee Related
- 2004-12-23 JP JP2006547322A patent/JP5006046B2/ja not_active Expired - Lifetime
- 2004-12-23 RS RS20110203A patent/RS51886B/sr unknown
- 2004-12-23 DK DK04815262.3T patent/DK1704148T3/da active
- 2004-12-23 CN CN200480041770.5A patent/CN1918162B/zh not_active Expired - Lifetime
- 2004-12-23 MY MYPI20045332A patent/MY143373A/en unknown
- 2004-12-23 PL PL04815262T patent/PL1704148T3/pl unknown
- 2004-12-23 EA EA200601217A patent/EA012295B1/ru not_active IP Right Cessation
- 2004-12-23 BR BRPI0418113A patent/BRPI0418113B8/pt active IP Right Grant
- 2004-12-23 DE DE602004031672T patent/DE602004031672D1/de not_active Expired - Lifetime
- 2004-12-23 NZ NZ548099A patent/NZ548099A/en not_active IP Right Cessation
- 2004-12-23 WO PCT/US2004/043160 patent/WO2005063763A1/en not_active Ceased
- 2004-12-23 SI SI200431670T patent/SI1704148T1/sl unknown
- 2004-12-23 EP EP04815262A patent/EP1704148B1/de not_active Expired - Lifetime
- 2004-12-23 CA CA2549627A patent/CA2549627C/en not_active Expired - Lifetime
- 2004-12-23 HR HR20110373T patent/HRP20110373T1/hr unknown
- 2004-12-23 SG SG200809413-8A patent/SG149045A1/en unknown
- 2004-12-23 AT AT04815262T patent/ATE500256T1/de active
- 2004-12-23 KR KR1020127011232A patent/KR20120066057A/ko not_active Ceased
- 2004-12-23 PT PT04815262T patent/PT1704148E/pt unknown
- 2004-12-23 AU AU2004309394A patent/AU2004309394B2/en not_active Expired
- 2004-12-27 AR ARP040104890A patent/AR047168A1/es not_active Application Discontinuation
2006
- 2006-06-18 IL IL176384A patent/IL176384A/en active IP Right Grant
- 2006-06-22 IS IS8519A patent/IS8519A/xx unknown
- 2006-06-29 US US11/477,639 patent/US7671064B2/en not_active Expired - Lifetime
- 2006-07-10 NO NO20063196A patent/NO336893B1/no not_active IP Right Cessation
- 2006-07-17 MA MA29192A patent/MA28298A1/fr unknown
- 2006-07-19 CR CR8519A patent/CR8519A/es unknown
2010
- 2010-02-18 US US12/708,306 patent/US8044064B2/en not_active Expired - Lifetime
2011
- 2011-06-01 CY CY20111100533T patent/CY1111524T1/el unknown
- 2011-09-16 US US13/234,501 patent/US8383813B2/en not_active Expired - Lifetime
2015
- 2015-09-23 NO NO20151245A patent/NO20151245A1/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
US20050143442A1 (en)	2005-06-30
AU2004309394A1 (en)	2005-07-14
CR8519A (es)	2007-06-06
PL1704148T3 (pl)	2011-07-29
EA200601217A1 (ru)	2006-12-29
US20120004253A1 (en)	2012-01-05
TW200530243A (en)	2005-09-16
KR101179372B1 (ko)	2012-09-03
WO2005063763A1 (en)	2005-07-14
US8044064B2 (en)	2011-10-25
US8383813B2 (en)	2013-02-26
US7671064B2 (en)	2010-03-02
US7169802B2 (en)	2007-01-30
DK1704148T3 (da)	2011-06-14
IL176384A (en)	2015-05-31
EP1704148A1 (de)	2006-09-27
US20100152196A1 (en)	2010-06-17
IL176384A0 (en)	2006-10-05
MA28298A1 (fr)	2006-11-01
NZ548099A (en)	2010-05-28
IS8519A (is)	2006-06-22
BRPI0418113A (pt)	2007-04-17
NO336893B1 (no)	2015-11-23
CA2549627C (en)	2012-12-11
CN1918162B (zh)	2014-05-14
EP1704148B1 (de)	2011-03-02
EA012295B1 (ru)	2009-08-28
BRPI0418113B1 (pt)	2020-04-14
RS51886B (sr)	2012-02-29
NO20063196L (no)	2006-09-20
MY158159A (en)	2016-09-15
KR20060127069A (ko)	2006-12-11
PT1704148E (pt)	2011-05-25
JP2007516293A (ja)	2007-06-21
NO20151245A1 (no)	2015-09-23
HK1096096A1 (en)	2007-05-25
AR047168A1 (es)	2006-01-11
MY143373A (en)	2011-04-29
HRP20110373T1 (hr)	2011-06-30
TWI355385B (en)	2012-01-01
JP5006046B2 (ja)	2012-08-22
US20060247294A1 (en)	2006-11-02
CA2549627A1 (en)	2005-07-14
KR20120066057A (ko)	2012-06-21
AU2004309394B2 (en)	2011-04-28
CY1111524T1 (el)	2015-08-05
BRPI0418113B8 (pt)	2021-05-25
SG149045A1 (en)	2009-01-29
DE602004031672D1 (de)	2011-04-14
SI1704148T1 (sl)	2011-06-30
CN1918162A (zh)	2007-02-21

Legal Events

Date

Code

Title

Description

2011-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1704148

Country of ref document: EP

Publication	Publication Date	Title
ATE500256T1 (de)	2011-03-15	Neue kondensierte pyrrolocarbazole
DE60328671D1 (de)	2009-09-17	Neue aminobenzamidderivate
DE602004007220D1 (de)	2007-08-09	Verbinder
DE602004020635D1 (de)	2009-05-28	Lanzetten betreffende verbesserungen
NO20033026D0 (no)	2003-07-01	Trehjuls kjöretöy
DK1581535T5 (da)	2009-12-21	Pyrrolopyridazinderivater
DE602004022898D1 (de)	2009-10-15	Verbinder
EP1663544A4 (de)	2010-06-02	Verbundlenkungszahnstange
SE0302091L (sv)	2005-03-08	Genomföring
DE602004010752D1 (de)	2008-01-31	Motorroller
ATE387440T1 (de)	2008-03-15	Neue 4-benzylidenpiperidinderivate
DE602004026397D1 (de)	2010-05-20	Verbinder
DE602005023145D1 (de)	2010-10-07	Neue androgene
DE502004012209D1 (de)	2011-03-31	Einparkhilfe
DE602004003978D1 (de)	2007-02-15	Verbinder
ATE425167T1 (de)	2009-03-15	Neue pyridothienopyrimidinderivate
ATE407113T1 (de)	2008-09-15	Neue verbindungen
DE602005008596D1 (de)	2008-09-11	Neue tetracyclische tetrahydrofuranderivate
DE60316553D1 (de)	2007-11-08	Verbinder
DE602004009500D1 (de)	2007-11-29	Verbinder
DE50309081D1 (de)	2008-03-13	Neue diketopyrrolopyrrolpigmente
DE602004029309D1 (de)	2010-11-11	Verbinder
DE602004000496D1 (de)	2006-05-11	Verbinder
FR2852345B1 (fr)	2012-02-10	Serrure
DE112004002110D2 (de)	2006-09-21	Behälter-Deckel-Kombination